Published in Obesity and Diabetes Week, November 12th, 2007
The combination of bupropion and naltrexone resulted in a 94% reduction of food intake in obese mice, greater than either drug alone; The drugs act in a part of the brain where food reward pathways are located; The combination directly increased firing of neurons associated with reduction...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.